Nasdaq Til News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Til. Real-time updates on events, politics, business and more.

Instil Bio Reports Fourth Quarter and Full Year 2022

March 31, 2023

Instil confirms cash runway beyond 2026 ITIL-306 phase 1 study anticipated to receive CTA clearance from UK MHRA in 2H'2023 Anticipate initial clinical...

United Kingdom United States Instil Bio Inc Regulatory Agency Anticipated Milestones Clinical Trial Application

Source: globenewswire.com

Instil Bio Announces Extension of Cash Runway Beyond 2026

January 31, 2023

Company anticipates cash resources to provide runway beyond 2026 Initial clinical data from the ITIL-306 program expected in 2023 Instil is consolidating...

United States United Kingdom Janhavi Mohite Bronson Crouch Instil Bio Inc Private Securities Litigation Reform Act

Source: globenewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Nasdaq Til News Today

Instil Bio Reports Fourth Quarter and Full Year 2022

Instil Bio Announces Extension of Cash Runway Beyond 2026

Explore More Categories